title: Millennium Pharmaceuticals
Lymecycline
Eskimo Pie
Marvel Entertainment
Singapore Sling (tax avoidance)
Level (airline)
Jones Pharma
Galderma
Sony Pictures
List of breweries in Australia
sentences: Millennium Pharmaceuticals, Inc., The Takeda Oncology Company was a leading biopharmaceutical company based in Cambridge, Massachusetts.
 Millennium has gradually been absorbed by its parent Takeda and renamed Takeda Oncology.
 The Company marketed Velcade (bortezomib) for injection, a cancer product, and has a growing clinical development pipeline of product candidates.
 Millennium's research, development and commercialization activities focused in two therapeutic areas: oncology and inflammation.
 By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium developed a line of new product candidates.
 It was one of the first companies to systematically search for genes linked to disease, but none of the drugs which it is marketing or has in clinical trial, with one partial exception, have been the results of that research.
 On May 14, 2008, Japanese company Takeda Pharmaceutical announced the completion of its acquisition of Millennium for US$25.00 per share in cash—a deal worth $8.8 billion.
 Takeda completed the acquisition through a tender offer and subsequent merger of a wholly owned subsidiary of Takeda into Millennium.
 Millennium is now a wholly owned subsidiary of Takeda.
Lymecycline is a tetracycline broad-spectrum antibiotic marketed by the pharmaceutical company Galderma.
 It is approximately 5,000 times more soluble than tetracycline base and is unique amongst tetracyclines in that it is absorbed by an active transport process across the intestinal wall, making use of the same fast and efficient mechanism by which carbohydrates are absorbed.
Eskimo Pie is a brand name for a chocolate-covered vanilla ice cream bar wrapped in foil, the first such dessert sold in the United States.
 It is now marketed by Nestlé, owners of Dreyer's of the Western United States, and Edy's of the Eastern United States.
 The product was introduced to New Zealand in the 1940s, and is produced by Tip Top who are now a subsidiary of Fonterra, the country's largest multinational company.
Marvel Entertainment, LLC (formerly Marvel Enterprises and Toy Biz, Inc., and marketed and stylized as MARVEL) is an American entertainment company founded in June 1998, merging Marvel Entertainment Group, Inc. and ToyBiz.
 The company is a wholly owned subsidiary of The Walt Disney Company, and is mainly known for its Marvel Comics, Marvel Animation, and Marvel Television units.
 Marvel Studios, formerly under the "Marvel" umbrella, became a subsidiary of The Walt Disney Studios, where it develops and produces a shared universe that shares continuity with shows produced by the television unit.
A Singapore Sling is a tax avoidance scheme in which a large multinational company sells products to a subsidiary owned by them in a jurisdiction with lower tax rates, which acts as a 'marketing hub'.
 The subsidiary then sells the product to end users, marking up its value and attributing the mark-up to various marketing activities undertaken by the subsidiary.
 The parent company retains a higher profit margin due to the lower tax rate.
 Singapore is a popular location of such subsidiaries, given its low tax rates and its willingness to grant large multinationals 'sweetheart deals' – an extremely low tax rate in exchange for locating the multinational's marketing activities in Singapore.
Level is a low-cost travel brand based at Barcelona–El Prat Airport in Spain.
 It is a wholly owned subsidiary of the multinational airline holding company International Airlines Group (IAG) that operates under an independent brand name.
 Level is marketed as a low-cost long-haul carrier, and began operations in June 2017 with service from Barcelona to Los Angeles, Oakland, Buenos Aires and Punta Cana.
Jones Pharma is a specialty pharmaceuticals manufacturer and marketer based in St. Louis, Missouri.
 The company was founded on March 16, 1981 by Dennis M. Jones and Judith Pearce Jones under the name Jones Medical Industries.
 The company completed its initial public offering in 1986, trading under the ticker symbol JMED on the NASDAQ.
 The primary therapeutic compounds marketed by the company include Thrombin-JMI and Levoxyl On May 30, 2000 the company became a wholly owned subsidiary of King Pharmaceuticals (NYSE:KG), based in Bristol, Tennessee.
 The market value of the company on its closing trade was $3.6 billion.
 Parent company King Pharmaceuticals was acquired by Pfizer in 2010.
Galderma S.A. is a pharmaceutical subsidiary specializing in the research, development and marketing of dermatological treatments and became a wholly owned subsidiary of Nestlé in 2014.
Sony Pictures Entertainment Inc. (known simply as Sony Pictures and abbreviated as SPE) is an American entertainment company that produces, acquires and distributes filmed entertainment (theatrical motion pictures, television programs and recorded videos) through multiple platforms.
 It is currently operated as a subsidiary of Sony Film Holding Inc., a subsidiary of Sony Entertainment Inc., which is itself a subsidiary of Sony Corporation of America, a subsidiary of Sony Americas Holding Inc., a subsidiary of the Tokyo-based multinational technology and media conglomerate Sony Corporation.
 Based in Culver City, California, it encompasses Sony's motion picture, television production and distribution units.
 Its group sales in the fiscal year 2015 (April 2015 – March 2016) has been reported to be of $8.3 billion.
Beer production in Australia has traditionally been dominated by regional producers.
 Since the 1980s there has been a steady stream of takeovers and amalgamations, and now the two major producers (who were once Australian owned) are Carlton & United Breweries (CUB) and Lion.
 In December 2011, CUB became a subsidiary of British multinational SABMiller (the then world second largest international brewing company) and in October 2016 CUB became 100% owned by Anheuser-Busch InBev (AB InBev) the world's largest brewing company based in Belgium.
 Since October 2009, Lion has been a subsidiary of Japanese brewer, Kirin Holdings Company Limited a brewing company established in 1885.
 The largest remaining Australian owned brewer is Coopers Brewery with a market share of about 4% of total beer volume sales in Australia.

Question: Question: Lymecycline is marketed by the company that became a subsidiary of what multinational in 2014? 

 Your answer will be verified with exact match score. To ensure correct verification, only provide the answer within the <answer> </answer> tags. Do not put any sentences or reasoning process within the <answer> </answer> tags. 

Supporting Information: Paragraph 0 

 Millennium Pharmaceuticals, Inc., The Takeda Oncology Company was a leading biopharmaceutical company based in Cambridge, Massachusetts.
 Millennium has gradually been absorbed by its parent Takeda and renamed Takeda Oncology.
 The Company marketed Velcade (bortezomib) for injection, a cancer product, and has a growing clinical development pipeline of product candidates.
 Millennium's research, development and commercialization activities focused in two therapeutic areas: oncology and inflammation.
 By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium developed a line of new product candidates.
 It was one of the first companies to systematically search for genes linked to disease, but none of the drugs which it is marketing or has in clinical trial, with one partial exception, have been the results of that research.
 On May 14, 2008, Japanese company Takeda Pharmaceutical announced the completion of its acquisition of Millennium for US$25.00 per share in cash—a deal worth $8.8 billion.
 Takeda completed the acquisition through a tender offer and subsequent merger of a wholly owned subsidiary of Takeda into Millennium.
 Millennium is now a wholly owned subsidiary of Takeda. 

--------------------------------

Paragraph 1 

 Lymecycline is a tetracycline broad-spectrum antibiotic marketed by the pharmaceutical company Galderma.
 It is approximately 5,000 times more soluble than tetracycline base and is unique amongst tetracyclines in that it is absorbed by an active transport process across the intestinal wall, making use of the same fast and efficient mechanism by which carbohydrates are absorbed. 

--------------------------------

Paragraph 2 

 Eskimo Pie is a brand name for a chocolate-covered vanilla ice cream bar wrapped in foil, the first such dessert sold in the United States.
 It is now marketed by Nestlé, owners of Dreyer's of the Western United States, and Edy's of the Eastern United States.
 The product was introduced to New Zealand in the 1940s, and is produced by Tip Top who are now a subsidiary of Fonterra, the country's largest multinational company. 

--------------------------------

Paragraph 3 

 Marvel Entertainment, LLC (formerly Marvel Enterprises and Toy Biz, Inc., and marketed and stylized as MARVEL) is an American entertainment company founded in June 1998, merging Marvel Entertainment Group, Inc. and ToyBiz.
 The company is a wholly owned subsidiary of The Walt Disney Company, and is mainly known for its Marvel Comics, Marvel Animation, and Marvel Television units.
 Marvel Studios, formerly under the "Marvel" umbrella, became a subsidiary of The Walt Disney Studios, where it develops and produces a shared universe that shares continuity with shows produced by the television unit. 

--------------------------------

Paragraph 4 

 A Singapore Sling is a tax avoidance scheme in which a large multinational company sells products to a subsidiary owned by them in a jurisdiction with lower tax rates, which acts as a 'marketing hub'.
 The subsidiary then sells the product to end users, marking up its value and attributing the mark-up to various marketing activities undertaken by the subsidiary.
 The parent company retains a higher profit margin due to the lower tax rate.
 Singapore is a popular location of such subsidiaries, given its low tax rates and its willingness to grant large multinationals 'sweetheart deals' – an extremely low tax rate in exchange for locating the multinational's marketing activities in Singapore. 

--------------------------------

Paragraph 5 

 Jones Pharma is a specialty pharmaceuticals manufacturer and marketer based in St. Louis, Missouri.
 The company was founded on March 16, 1981 by Dennis M. Jones and Judith Pearce Jones under the name Jones Medical Industries.
 The company completed its initial public offering in 1986, trading under the ticker symbol JMED on the NASDAQ.
 The primary therapeutic compounds marketed by the company include Thrombin-JMI and Levoxyl On May 30, 2000 the company became a wholly owned subsidiary of King Pharmaceuticals (NYSE:KG), based in Bristol, Tennessee.
 The market value of the company on its closing trade was $3.6 billion.
 Parent company King Pharmaceuticals was acquired by Pfizer in 2010. 

--------------------------------

Paragraph 6 

 Galderma S.A. is a pharmaceutical subsidiary specializing in the research, development and marketing of dermatological treatments and became a wholly owned subsidiary of Nestlé in 2014. 

--------------------------------

Paragraph 7 

 Beer production in Australia has traditionally been dominated by regional producers.
 Since the 1980s there has been a steady stream of takeovers and amalgamations, and now the two major producers (who were once Australian owned) are Carlton & United Breweries (CUB) and Lion.
 In December 2011, CUB became a subsidiary of British multinational SABMiller (the then world second largest international brewing company) and in October 2016 CUB became 100% owned by Anheuser-Busch InBev (AB InBev) the world's largest brewing company based in Belgium.
 Since October 2009, Lion has been a subsidiary of Japanese brewer, Kirin Holdings Company Limited a brewing company established in 1885.
 The largest remaining Australian owned brewer is Coopers Brewery with a market share of about 4% of total beer volume sales in Australia. 

--------------------------------

 


Answer: Nestlé